Scientific intelligence, biopharma primary / secondary research, competitive intelligence and regulatory intelligence professionals will benefit from cognizance of key trends in the biopharma industry. For an instance: recent investigation of the Indian drug market has gathered substantial attention, as India seems poised to turn a major player in the pharmaceutical segment worldwide. This report provides some key trends and predictions.
BY 2020: INDIAN PHARMACEUTICAL INDUSTRY TO REACH $55 BILLION
According to India Ratings, a Fitch company, the Indian pharmaceutical industry is estimated to grow at 20 % compound annual growth rate (CAGR) over the next 5 years. The Indian pharma industry, which is expected to grow over 15 % per annum between 2015 and 2020, will outperform the global pharma industry, which is set to grow at an annual rate of 5 % between the same period. Presently the market size of the pharmaceutical industry in India stands at US$ 20 billion. This level of growth is predicted even in the face of an anticipated slowdown in exports, which are projected at a CAGR of 7.98%.
How can an export market experience concurrent slowdown and growth? According to the Senior Professionals there are number of causes for this slowdown:
Continue Reading @ https://goo.gl/eYRhsm
For more updates visit HarNeedi.com